Leukemia inhibitory factor is involved in the pathogenesis of NSCLC through activation of the STAT3 signaling pathway

Leukemia inhibitory factor (LIF) is a tumor promoter in several cancer types. However, the role of LIF in non-small cell lung cancer (NSCLC) remains to be explored. The present study explored the hypothesis that LIF is important for NSCLC development by measuring LIF expression and its downstream si...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huaying, Si, Sai'nv, Jiang, Mingjun, Chen, Liping, Huang, Kefeng, Yu, Wanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299032/
https://www.ncbi.nlm.nih.gov/pubmed/34386085
http://dx.doi.org/10.3892/ol.2021.12924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299032/
https://www.ncbi.nlm.nih.gov/pubmed/34386085
http://dx.doi.org/10.3892/ol.2021.12924

Ejemplares similares